Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration, and cardiovascular disease.
|HQ||South San Francisco, CA, US||Map|
Encoded Therapeutics total Funding
Encoded Therapeutics latest funding size
Time since last funding
|2 years ago|
Encoded Therapeutics investors
|Menlo Ventures, Venrock, Farallon Capital Management, ARCH Venture Partners, Altitude Life Science Ventures, RTW Investments, Boxer Capital, GV, Matrix Capital Management, Illumina Accelerator, HBM Genomics, Alexandria Venture Investments, RTW Investments LLC, Illumina Ventures, Meritech Capital, Nolan Capital, SoftBank Vision Fund 21|
When was Encoded Therapeutics founded?
Encoded Therapeutics was founded in 2014.
Who are Encoded Therapeutics key executives?
Encoded Therapeutics's key executives are Kartik Ramamoorthi, Stephanie Tagliatela and Nancy Boman.
How many employees does Encoded Therapeutics have?
Encoded Therapeutics has 177 employees.
Who are Encoded Therapeutics competitors?
Competitors of Encoded Therapeutics include Alector, OmniSpirant and ToolGen.
Where is Encoded Therapeutics headquarters?
Encoded Therapeutics headquarters is located at 341 Oyster Point Blvd, South San Francisco.
Where are Encoded Therapeutics offices?
Encoded Therapeutics has an office in South San Francisco.
How many offices does Encoded Therapeutics have?
Encoded Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies